Enveric Biosciences, Inc. Quarterly Debt-to-equity in % from Q3 2016 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Enveric Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2016 to Q4 2022.
  • Enveric Biosciences, Inc. Debt-to-equity for the quarter ending December 31, 2022 was 29.7 %, a 12.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 29.7 +3.35 +12.7% Dec 31, 2022
Q3 2022 27.7 +0.03 +0.11% Sep 30, 2022
Q2 2022 26.2 -46 -63.7% Jun 30, 2022
Q1 2022 26 -215 -89.2% Mar 31, 2022
Q4 2021 26.4 +767 Dec 31, 2021
Q3 2021 27.7 +445 Sep 30, 2021
Q2 2021 72.2 -925 -92.8% Jun 30, 2021
Q1 2021 241 -22.1 -8.42% Mar 31, 2021
Q4 2020 -740 -901 -559% Dec 31, 2020
Q3 2020 -417 -618 -307% Sep 30, 2020
Q2 2020 997 +867 +666% Jun 30, 2020
Q1 2020 263 +126 +92.4% Mar 31, 2020
Q4 2019 161 +26.9 +20.1% Dec 31, 2019
Q3 2019 201 +81.3 +67.7% Sep 30, 2019
Q2 2019 130 -48.6 -27.2% Jun 30, 2019
Q1 2019 137 -65.2 -32.3% Mar 31, 2019
Q4 2018 134 -92.6 -40.8% Dec 31, 2018
Q3 2018 120 -131 -52.2% Sep 30, 2018
Q2 2018 179 -111 -38.3% Jun 30, 2018
Q1 2018 202 -122 -37.7% Mar 31, 2018
Q4 2017 227 -258 -53.2% Dec 31, 2017
Q3 2017 251 -853 -77.2% Sep 30, 2017
Q2 2017 290 Jun 30, 2017
Q1 2017 324 Mar 31, 2017
Q4 2016 485 Dec 31, 2016
Q3 2016 1.1K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.